BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37315748)

  • 1. Glioma-derived small extracellular vesicles induce pericyte-phenotype transition of glioma stem cells under hypoxic conditions.
    Cheng Y; Li S; Hou Y; Wan W; Wang K; Fu S; Yuan Y; Yang K; Ye X
    Cell Signal; 2023 Sep; 109():110754. PubMed ID: 37315748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular vesicles derived from hypoxic glioma stem-like cells confer temozolomide resistance on glioblastoma by delivering miR-30b-3p.
    Yin J; Ge X; Shi Z; Yu C; Lu C; Wei Y; Zeng A; Wang X; Yan W; Zhang J; You Y
    Theranostics; 2021; 11(4):1763-1779. PubMed ID: 33408780
    [No Abstract]   [Full Text] [Related]  

  • 3. Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development.
    Kucharzewska P; Christianson HC; Welch JE; Svensson KJ; Fredlund E; Ringnér M; Mörgelin M; Bourseau-Guilmain E; Bengzon J; Belting M
    Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7312-7. PubMed ID: 23589885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfer of MicroRNA via Macrophage-Derived Extracellular Vesicles Promotes Proneural-to-Mesenchymal Transition in Glioma Stem Cells.
    Zhang Z; Xu J; Chen Z; Wang H; Xue H; Yang C; Guo Q; Qi Y; Guo X; Qian M; Wang S; Qiu W; Gao X; Zhao R; Guo X; Li G
    Cancer Immunol Res; 2020 Jul; 8(7):966-981. PubMed ID: 32350000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteasome inhibition with bortezomib induces cell death in GBM stem-like cells and temozolomide-resistant glioma cell lines, but stimulates GBM stem-like cells' VEGF production and angiogenesis.
    Bota DA; Alexandru D; Keir ST; Bigner D; Vredenburgh J; Friedman HS
    J Neurosurg; 2013 Dec; 119(6):1415-23. PubMed ID: 24093630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-induced galectin-8 maintains stemness in glioma stem cells via autophagy regulation.
    Liu D; Zhu H; Cheng L; Li R; Ma X; Wang J; Wang J; Zhang S; Li Y; Shu K; Yu X; Li C
    Neuro Oncol; 2024 May; 26(5):872-888. PubMed ID: 38158714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Glioma Stem Cell-Derived Pericytes Disrupts the Blood-Tumor Barrier and Improves Chemotherapeutic Efficacy.
    Zhou W; Chen C; Shi Y; Wu Q; Gimple RC; Fang X; Huang Z; Zhai K; Ke SQ; Ping YF; Feng H; Rich JN; Yu JS; Bao S; Bian XW
    Cell Stem Cell; 2017 Nov; 21(5):591-603.e4. PubMed ID: 29100012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor vasculature and glioma stem cells: Contributions to glioma progression.
    Jhaveri N; Chen TC; Hofman FM
    Cancer Lett; 2016 Oct; 380(2):545-551. PubMed ID: 25527451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notch1 stimulation induces a vascularization switch with pericyte-like cell differentiation of glioblastoma stem cells.
    Guichet PO; Guelfi S; Teigell M; Hoppe L; Bakalara N; Bauchet L; Duffau H; Lamszus K; Rothhut B; Hugnot JP
    Stem Cells; 2015 Jan; 33(1):21-34. PubMed ID: 24898819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth factor independence underpins a paroxysmal, aggressive Wnt5a
    Trivieri N; Visioli A; Mencarelli G; Cariglia MG; Marongiu L; Pracella R; Giani F; Soriano AA; Barile C; Cajola L; Copetti M; Palumbo O; Legnani F; DiMeco F; Gorgoglione L; Vescovi AL; Binda E
    J Exp Clin Cancer Res; 2022 Apr; 41(1):139. PubMed ID: 35414102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic, Metabolomic, and Fatty Acid Profiling of Small Extracellular Vesicles from Glioblastoma Stem-Like Cells and Their Role in Tumor Heterogeneity.
    Lokumcu T; Iskar M; Schneider M; Helm D; Klinke G; Schlicker L; Bethke F; Müller G; Richter K; Poschet G; Phillips E; Goidts V
    ACS Nano; 2024 Jan; 18(3):2500-2519. PubMed ID: 38207106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44 expression in the tumor periphery predicts the responsiveness to bevacizumab in the treatment of recurrent glioblastoma.
    Nishikawa M; Inoue A; Ohnishi T; Yano H; Kanemura Y; Kohno S; Ohue S; Ozaki S; Matsumoto S; Suehiro S; Nakamura Y; Shigekawa S; Watanabe H; Kitazawa R; Tanaka J; Kunieda T
    Cancer Med; 2021 Mar; 10(6):2013-2025. PubMed ID: 33543833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer stem cells in glioblastoma--molecular signaling and therapeutic targeting.
    Huang Z; Cheng L; Guryanova OA; Wu Q; Bao S
    Protein Cell; 2010 Jul; 1(7):638-55. PubMed ID: 21203936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shedding of bevacizumab in tumour cells-derived extracellular vesicles as a new therapeutic escape mechanism in glioblastoma.
    Simon T; Pinioti S; Schellenberger P; Rajeeve V; Wendler F; Cutillas PR; King A; Stebbing J; Giamas G
    Mol Cancer; 2018 Aug; 17(1):132. PubMed ID: 30165850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDH5 is specifically activated in glioblastoma stemlike cells and contributes to vasculogenic mimicry induced by hypoxia.
    Mao XG; Xue XY; Wang L; Zhang X; Yan M; Tu YY; Lin W; Jiang XF; Ren HG; Zhang W; Song SJ
    Neuro Oncol; 2013 Jul; 15(7):865-79. PubMed ID: 23645533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy-induced KDR/VEGFR-2 activation promotes the formation of vasculogenic mimicry by glioma stem cells.
    Wu HB; Yang S; Weng HY; Chen Q; Zhao XL; Fu WJ; Niu Q; Ping YF; Wang JM; Zhang X; Yao XH; Bian XW
    Autophagy; 2017 Sep; 13(9):1528-1542. PubMed ID: 28812437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth.
    Cheng L; Huang Z; Zhou W; Wu Q; Donnola S; Liu JK; Fang X; Sloan AE; Mao Y; Lathia JD; Min W; McLendon RE; Rich JN; Bao S
    Cell; 2013 Mar; 153(1):139-52. PubMed ID: 23540695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversing glioma malignancy: a new look at the role of antidepressant drugs as adjuvant therapy for glioblastoma multiforme.
    Bielecka-Wajdman AM; Lesiak M; Ludyga T; Sieroń A; Obuchowicz E
    Cancer Chemother Pharmacol; 2017 Jun; 79(6):1249-1256. PubMed ID: 28500556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cells.
    Kim SH; Kim EJ; Hitomi M; Oh SY; Jin X; Jeon HM; Beck S; Jin X; Kim JK; Park CG; Chang SY; Yin J; Kim T; Jeon YJ; Song J; Lim YC; Lathia JD; Nakano I; Kim H
    Cell Death Differ; 2015 Sep; 22(9):1517-25. PubMed ID: 25721045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Talin1 targeting potentiates anti-angiogenic therapy by attenuating invasion and stem-like features of glioblastoma multiforme.
    Kang W; Kim SH; Cho HJ; Jin J; Lee J; Joo KM; Nam DH
    Oncotarget; 2015 Sep; 6(29):27239-51. PubMed ID: 26336988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.